Stock 603880 JIANGSU NANFANG MEDICAL CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

News Jiangsu Nanfang Medical Co., Ltd.

Equities

603880

CNE100002WH0

End-of-day quote Shanghai S.E.
Other stock markets
 06:00:00 2024-04-23 pm EDT 		5-day change 1st Jan Change
3.49 CNY 0.00% Intraday chart for Jiangsu Nanfang Medical Co., Ltd. +0.87% -31.43%
Mar. 29 Jiangsu Nanfang Medical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
2023 Jiangsu Nanfang Medical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023 CI

Summary

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Jiangsu Nanfang Medical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023
CI
Jiangsu Nanfang Medical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023
CI
Jiangsu Nanfang Medical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023
CI
Ren Weiguo signed share transfer agreement to acquire 8% stake in Jiangsu Nanfang Medical Co., Ltd. from Li Ping for CNY 99.9 million.
CI
Jiangsu Nanfang Medical Co., Ltd.(SHSE:603880) dropped from Shanghai Stock Exchange A Share Index
CI
Jiangsu Nanfang Medical Co., Ltd.(SHSE:603880) dropped from Shanghai Stock Exchange Composite Index
CI
Suzhou Fengruida Optoelectronics Technology Co., Ltd. signed a share transfer agreement to acquire 8% stake in Jiangsu Nanfang Medical Co., Ltd. from Li Ping for approximately CNY 140 million.
CI
Jiangsu Nanfang Medical Co., Ltd. announced that it expects to receive CNY 299.200902 million in funding from Suzhou Fengruida Optoelectronics Technology Co., Ltd.
CI
Jiangsu Nanfang Medical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023
CI
Jiangsu Nanfang Medical Unit to Apply For 100 Million Yuan Bank Loan
MT
Jiangsu Nanfang Medical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022
CI
Jiangsu Nanfang Medical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022
CI
Jiangsu Nanfang Medical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022
CI
Jiangsu Nanfang Medical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2021
CI
Inner Mongolia Huaxi Biotechnology Co., Ltd. announced that it expects to receive CNY 20 million in funding from Jiangsu Nanfang Medical Co., Ltd.
CI
Jiangsu Nanfang Medical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2021
CI
Jiangsu Nanfang Medical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2021
CI
Jiangsu Nanfang Medical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2021
CI
Jiangsu Nanfang Medical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2020
CI
Shen Zhezhong cancelled the acquisition of 60% stake in Shanghai Milene Biotechnology Co., Ltd.
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. 603880 Stock
  4. News Jiangsu Nanfang Medical Co., Ltd.